Media Mentions and Publications

    • Beth Z Clark, Daniel J Farrugia, et al – Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer.- Am J Clin Pathol. 2018 Mar 7;149(4):332-343 (link to full text PDF publication).
    • Daniel J Farrugia MD PhD – Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors – May 26, 2017 (link to full text PDF publication).
Daniel J Farrugia MD PhD Administrator
Director, Centegra Comprehensive Breast Program
Daniel Farrugia MD PhD is a fellowship-trained board-certified breast surgeon in the northern suburbs of Chicago. He is the Medical Director of the Centegra Comprehensive Breast Program. He trained at Mayo Clinic, the University of Florida, and the University of Pittsburgh. He received several awards for his research in breast cancer which has been published in top international journals, and has been cited over a thousand times in the medical literature.

If you have a suggestion for a future blog post about breast health, please CLICK HERE.
follow me